Innovative Herpes Virus-Based Vaccine Shows Potential in Cancer Treatment Without Side Effects
A novel herpes virus-based cancer vaccine shows promise in targeting tumors effectively without causing side effects, offering new hope for cancer therapies.
A groundbreaking study from Åbo Akademi University in Finland reveals that genetically modified herpes simplex virus can be engineered to act as an effective and safe cancer vaccine. Herpes simplex virus, commonly known for causing cold sores, is present in most individuals. Researchers have identified that by removing a specific virulence gene, which typically makes the virus harmful, the virus can be repurposed to target and destroy cancer cells without damaging healthy tissues.
This innovative approach involves inserting a gene that encodes decorin, a crucial protein involved in connective tissue regulation, wound healing, and blood vessel formation. Notably, decorin is often absent in many human cancers, including those characterized by excessive blood vessel growth or angiogenesis, which can hinder the effectiveness of traditional treatments. By restoring decorin expression within the vaccine, the therapy aims to inhibit tumor blood vessel formation, thereby starving the cancer and making it more susceptible to treatment.
Verifying its efficacy, the research demonstrated that decorin-enhanced vaccines significantly boosted the killing of lung cancer cells. Furthermore, these vaccines can be administered intranasally, which was successfully tested on mice, providing a less invasive delivery method. Remarkably, in chicken embryo models of liver cancer, the vaccine reduced tumor-associated blood vessel growth by 40%, with treated tumors developing normal vasculature, even after blood vessel formation had started. Importantly, no adverse side effects were observed, indicating the vaccine's specificity and safety.
Overall, these findings suggest a promising future for cancer vaccines that are not only effective but also free of side effects. By targeting blood vessel growth around tumors, such vaccines could improve drug delivery and treatment outcomes, potentially complementing existing therapies. This research paves the way for new, less invasive, and safer cancer treatment options.
Source: https://medicalxpress.com/news/2025-10-herpes-virus-based-vaccine-tumors.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Genetic Insights into Systemic Sclerosis Through Exome Sequencing and Machine Learning
A novel study integrating exome sequencing and machine learning uncovers new genetic factors, including MICB, contributing to systemic sclerosis risk, advancing personalized treatment options.
Obesity Medications Show Promise in Enhancing Emotional Well-Being Alongside Physical Health Benefits
Discover how GLP1 receptor agonists used for obesity and diabetes management may also improve emotional well-being without increasing psychiatric risks, providing a holistic approach to health.
Combination Therapy Extends Survival in Patients with Severe Heart Disease
A groundbreaking study shows that combining valve replacement with targeted drug therapy significantly improves survival in patients with severe heart conditions, including aortic stenosis and cardiac amyloidosis.
Using Multifocal Contact Lenses to Slow Eye Growth and Reduce Childhood Myopia
Innovative high-add multifocal contact lenses show promise in slowing eye growth and reducing myopia progression in children, according to recent studies highlighting biological mechanisms involved in eye development.